跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pristinamycin
首页
药物
Pristinamycin
Experimental
Small Molecule
Pristinamycin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
CAS 编号
270076-60-3
UNII ID
4O8O7Q7IU4
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pristinamycin IIA crystal
申请人: ZHEJIANG MED XINCHANG PHARM
优先权: 2012
CN
Pristinamycin IA crystal
申请人: ZHEJIANG MED XINCHANG PHARM
优先权: 2012
CN
Method for separating and purifying pristinamycin
申请人: BEIJING KELANG HONGDA TECHNOLOGY CO LTD
优先权: 2011
CN
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
申请人: FLEURIR ABX LLC
优先权: 2015
US
5 件公开
PRISTINAMYCIN IA AND FLOPRISTIN COMBINATIONS IN TREATING OR PREVENTING BACTERIAL INFECTIONS
申请人: AIMMAX THERAPEUTICS INC
优先权: 2021
CN
EP
US
WO
4 件公开
Mycoplasma pneumoniae and mycoplasma gallisepticum resistant pristinamycin composition and application thereof
申请人: SHANGHAI LAIYI BIOMEDICAL RES AND DEVELOPMENT CENTER CO LTD
优先权: 2022
CN
New gene participating in negative control of biosynthesis of pristinamycin and applications thereof
申请人: SHANGHAI INST BIOL SCIENCES
优先权: 2012
CN
Mixed albumin nanoparticle oral preparation of pristinamycin IA/IIA type and preparation method thereof
申请人: SHANGHAI LAIYI BIOMEDICAL RES AND DEVELOPMENT CENTER CO LTD
优先权: 2022
CN
药物
反馈